AFC-HD AMS Life Science (2927.T) Earnings Analysis

AFC-HD AMS Life Science (2927.T) next reports earnings on 2026-10-09. Trailing P/E 10.28.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 2927.T next report earnings?

Next earnings date2026-10-09
Consensus EPS estimaten/a
Revenue estimaten/a

2927.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-1525.06 JPYn/an/an/a
2026-04-1419.06 JPYn/an/an/a
2026-01-1436.7 JPYn/an/an/a
2025-08-302.56 JPYn/an/an/a
2025-07-1437.77 JPYn/an/an/a
2025-04-1429.96 JPYn/an/an/a
2025-01-1432.7 JPYn/an/an/a
2024-10-1522.86 JPYn/an/an/a

2927.T valuation and analyst view

Trailing P/E10.28
Trailing EPS82.589 JPY
Price / book0.77
Dividend yield4.20%
Market cap12.54B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is AFC-HD AMS Life Science (2927.T)'s next earnings date?

AFC-HD AMS Life Science is next scheduled to report on 2026-10-09.

Did 2927.T beat earnings last quarter?

Consensus estimate data was not available for 2927.T's 2026-07-15 report.

What is 2927.T's current P/E ratio and EPS?

2927.T trades at a trailing P/E of 10.28 on trailing EPS of 82.58891638887181 JPY.

What do analysts rate 2927.T?

2927.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.